UK Markets close in 6 hrs 39 mins

Merck Kommanditgesellschaft auf Aktien (MRK.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
94.60-0.58 (-0.61%)
As of 10:35AM CEST. Market open.
Full screen
Previous close95.18
Open94.75
Bid94.55 x 6700
Ask94.60 x 11200
Day's range94.07 - 95.45
52-week range90.00 - 115.20
Volume117,907
Avg. volume393,834
Market cap41.31B
BetaN/A
PE ratio (TTM)26.37
EPS (TTM)3.59
Earnings date3 Aug 2017
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • What's in the Cards for Merck KGaA (MKGAF) in Q2 Earnings?
    Zacks3 days ago

    What's in the Cards for Merck KGaA (MKGAF) in Q2 Earnings?

    Merck KGaA???s (MKGAF) Life Science segment is expected to perform well following the approval of Bavencio.

  • PR Newswire6 days ago

    EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

    DARMSTADT, Germany and NEW YORK , July 20, 2017 /PRNewswire/ -- Not intended for UK-based media     If approved,   avelumab   could   be   the   first   immunotherapy   treatment   indicated   for   this ...

  • EU charges Merck KGaA, GE, Canon over merger rules
    Reuters21 days ago

    EU charges Merck KGaA, GE, Canon over merger rules

    General Electric (GE.N), German drugmaker Merck KGaA (MRCG.DE), and Japan's Canon (7751.T) risk hefty fines after EU antitrust regulators accused them of providing misleading information during separate merger deals. The European Commission said on Thursday that it had sent three separate charge sheets known as statements of objections to General Electric, Merck KGaA and Canon after investigations showed breaches of the bloc's merger rules. While the charges will not affect the EU approvals of the deals, they could lead to fines of up to 1 percent of global revenue for Merck KGaA and General Electric, and up to 10 percent for Canon.